IP Library Patent Application 14823891
Patent Application
App. No. 14/823,891

PLASMONIC SUB-100 NM NANOMATRYOSHKAS THAT CONFINE CONTRAST AGENTS WITHIN LAYERS OF METAL

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/823,891
Abstract

A magnetic resonance imaging enhancement agent includes a plurality of particles. Each particle including a metal core; a dielectric shell disposed on the metal core including water and at least one MRI contrast agent; and a metal shell disposed on the exterior surface of the dielectric shell that encapsulates the dielectric shell.

Claims (51)

1 . A Magnetic Resonance Imaging (MRI) enhancement agent, comprising:

a plurality of particles, each particle comprising:

a metal core;

a dielectric shell disposed on the metal core comprising water and at least one MRI contrast agent; and

a metal shell disposed on the exterior surface of the dielectric shell that encapsulates the dielectric shell.

2 . The magnetic resonance imaging enhancement agent of claim 1 , wherein a radius of the metal core is less than 40 nm.

3 . The magnetic resonance imaging enhancement agent of claim 1 , wherein a radius of the metal core is approximately 25 nm.

4 . The magnetic resonance imaging enhancement agent of claim 1 , wherein a radius of the metal core is less than 25 nm.

5 . The magnetic resonance imaging enhancement agent of claim 1 , wherein a thickness of the silica shell is less than 20 nm.

6 . The magnetic resonance imaging enhancement agent of claim 1 , wherein a thickness of the metal shell is between 1 and 20 nm.

7 . The magnetic resonance imaging enhancement agent of claim 1 , wherein at least a portion of the plurality of particles supports a plasmon resonance centered at greater than 400 nm and less than 1200 nm.

8 . The magnetic resonance imaging enhancement agent of claim 1 , wherein at least a portion of the plurality of particles supports a plasmon resonance centered at 810 nm.

9 . The magnetic resonance imaging enhancement agent of claim 1 , wherein the silica shell is doped with an amine.

10 . The magnetic resonance imaging enhancement agent of claim 9 , wherein the amine is 3-aminopropyl-triethoxysilane.

11 . The MRI enhancement agent of claim 1 , wherein the MRI contrast agent is comprised of at least one selected from the group containing a type 1 contrast agent and a type 2 contrast agent.

12 . The magnetic resonance imaging enhancement agent of claim 11 , wherein the type 1 contrast agent is manganese oxide and the type 2 contrast agent is iron oxide.

13 . The magnetic resonance imaging enhancement agent of claim 11 , wherein the type 1 contrast agent is a lanthanide.

14 . The magnetic resonance imaging enhancement agent of claim 13 , wherein the type 1 contrast agent is chelated.

15 . The magnetic resonance imaging enhancement agent of claim 13 , wherein the lanthanide is gadolinium.

16 . The magnetic resonance imaging enhancement agent of claim 14 , wherein the chelate is diethylene triamine pentaacetic acid.

17 . The magnetic resonance imaging enhancement agent of claim 1 , wherein the magnetic resonance imaging enhancement agent is comprised of at least one type 1 contrast agent and at least one type 2 contrast agent.

18 . The magnetic resonance imaging enhancement agent of claim 17 , wherein the type 1 contrast agent is a lanthanide.

19 . The magnetic resonance imaging enhancement agent of claim 18 , wherein the lanthanide is gadolinium.

20 . The magnetic resonance imaging enhancement agent of claim 17 , wherein the type 1 contrast agent is manganese oxide and the type 2 contrast agent is iron oxide.

21 . The magnetic resonance imaging enhancement agent of claim 1 , wherein the metal core is gold.

22 . The magnetic resonance imaging enhancement agent of claim 1 , wherein the metal shell is gold.

23 . The magnetic resonance imaging enhancement agent of claim 1 , wherein the metal core is silver.

24 . The magnetic resonance imaging enhancement agent of claim 1 , wherein the metal shell is silver.

25 . A method of producing a Magnetic Resonance Imaging (MRI) enhancement particle, comprising:

coating a metal core with a dielectric to obtain a metal core with a dielectric coating;

loading the dielectric coating with a solution comprising water and a MRI contrast agent to obtain a loaded dielectric coating;

etching the loaded dielectric coating to a desired thickness to obtain an etched dielectric coating;

seeding the exterior of the etched dielectric coating with a metal to obtain a seeded dielectric coating; and

coating the seeded dielectric coating with a second metal to obtain the magnetic resonance imaging enhancement particle.

26 . The method of claim 25 , wherein the dielectric shell is doped with an amine.

27 . The method of claim 26 , wherein the amine is 3-aminopropyl-triethoxysilane.

28 . The method of claim 25 , wherein the MRI contrast agent is comprised of at least one selected from the group containing a type 1 contrast agent and a type 2 contrast agent.

29 . The method of claim 28 , wherein the type 1 contrast agent is a lanthanide.

30 . The method of claim 29 , wherein the lanthanide is gadolinium.

31 . The method of claim 25 , wherein the type 1 contrast agent is chelated.

32 . The method of claim 31 , wherein the chelate is diethylene triamine pentaacetic acid.

33 . The method of claim 28 , wherein the type 1 contrast agent is manganese oxide and the type 2 contrast agent is iron oxide.

34 . The method of claim 25 , wherein the MRI contrast agent is comprised of at least one type 1 contrast agent and at least one type 2 contrast agent.

35 . The method of claim 32 , wherein the type 1 contrast agent is a lanthanide.

36 . The method of claim 33 , wherein the lanthanide is gadolinium.

37 . The method of claim 32 , wherein the type 1 contrast agent is manganese oxide and the type 2 contrast agent is iron oxide.

38 . The method of claim 25 , wherein the metal core is gold.

39 . The method of claim 25 , wherein the metal core is silver.

40 . The method of claim 25 , wherein the second metal is silver.

41 . The method of claim 25 , wherein the second metal is gold.

42 . The method of claim 25 , wherein the dielectric shell is silica.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 16, 2017
From: RICE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043867/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2016
From: HALAS, NANCY J.; AYALA-OROZCO, CICERON; BISHNOI, SANDRA
To: WILLIAM MARSH RICE UNIVERSITY
Reel/Frame 037719/0710 →